SCHEMBL15501476

SCHEMBL15501476

c1ccc(-c2nc(-c3ccc(-c4ccc5oc6ccccc6c5c4)cc3)nc(-c3ccc(-c4cc5ccccc5c5ccccc45)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.43
▸ PLA2G4A P47712 3/20 0.43
▸ CYP11B1 P15538 1/20 0.41
▸ KDM4E B2RXH2 7/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ MAPT P10636 6/20 0.41
▸ HPGD P15428 5/20 0.41
▸ TSHR P16473 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ CASP7 P55210 1/20 0.41
▸ GPR84 Q9NQS5 1/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ MAOB P27338 1/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15501318 1.00 PLA2G2A (0.43) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1
SCHEMBL15501606 0.95 PLA2G2A (0.42) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1
SCHEMBL15501398 0.94 KMT2A (0.41) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1
SCHEMBL15501315 0.94 KMT2A (0.41) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1
SCHEMBL21263465 0.92 PLA2G2A (0.40) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1
SCHEMBL24990440 0.92 MAPT (0.42) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1
SCHEMBL24217173 0.92 CYP11B1 (0.45) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1
SCHEMBL17899244 0.92 KMT2A (0.40) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1
SCHEMBL22141165 0.90 KDM4E (0.46) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1
SCHEMBL22240794 0.90 CYP11B1 (0.41) PLA2G2APLA2G4ACYP11B1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029120-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 — — US disclosed
US-12029120-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 — — US disclosed
US-20220123223-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2022-04-21 — — US disclosed
US-9209406-B2 Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-12-08 — — US disclosed
US-9209406-B2 Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-12-08 — — US disclosed
US-20140073784-A1 AROMATIC HETEROCYCLIC DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-03-13 — — US disclosed
US-20140073784-A1 AROMATIC HETEROCYCLIC DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-03-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12029120-B2 Organic electroluminescence element and electronic device RPS10, H1-10, OR10J3 PLA2G2A 3399/4885PLA2G4A 4153/4885CYP11B1 1259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback